• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人自身免疫性大疱性皮肤病:病理生理学、诊断和治疗的最新进展。

Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management.

机构信息

Department of Dermatology, University of Cincinnati, College of Medicine, 231 Albert Sabin Way, P.O. Box 670592, Cincinnati, OH 45267-0592, USA.

出版信息

Drugs Aging. 2010 Jan 1;27(1):1-19. doi: 10.2165/11318600-000000000-00000.

DOI:10.2165/11318600-000000000-00000
PMID:20030429
Abstract

Elderly individuals are susceptible to autoimmune bullous dermatoses (ABDs), which may be associated with high morbidity and mortality. ABDs result from an autoimmune response to components of the basement membrane zone at the dermal-epidermal junction or desmosomes. Bullous pemphigoid results from autoimmunity to hemidesmosomal proteins present in the basement membrane of stratified squamous epithelia. Patients present with tense blisters in flexural areas of the skin. Mild disease may be treated with potent topical corticosteroids, while extensive disease usually requires systemic corticosteroids or systemic immunosuppressive agents such as azathioprine. Mucosal pemphigoid affects one or more mucous membranes that are lined by stratified squamous epithelia. The two most commonly involved sites are the eye and the oral cavity. Lesions frequently result in scar formation that may cause blindness. Patients with severe disease or ocular involvement require aggressive therapy with corticosteroids and cyclophosphamide. Epidermolysis bullosa acquisita results from autoimmunity to type VII collagen in the anchoring fibrils of the basement membrane. Lesions may either arise on an inflammatory base or be non-inflammatory and result primarily from trauma. Treatment options include corticosteroids, dapsone, ciclosporin, methotrexate and plasmapheresis/immunoapheresis. Paraneoplastic pemphigus results from autoimmunity to multiple desmosomal antigens. The disorder is associated with neoplasms, especially leukaemia, lymphoma and thymoma. Patients present with stomatitis and polymorphous skin eruption. The disease may respond to successful treatment of the underlying neoplasm or may require immunosuppressive therapy.

摘要

老年人易患自身免疫性大疱性皮肤病 (ABDs),其发病率和死亡率较高。ABDs 是由于自身免疫反应导致真皮-表皮交界处基底膜带或桥粒的成分受损引起的。大疱性类天疱疮是由桥粒蛋白自身免疫引起的,这些蛋白存在于复层鳞状上皮的基底膜中。患者表现为皮肤屈侧紧张性水疱。轻度疾病可采用强效局部皮质类固醇治疗,而广泛疾病通常需要全身皮质类固醇或全身免疫抑制剂,如硫唑嘌呤。黏膜类天疱疮影响一个或多个由复层鳞状上皮衬里的黏膜。最常受累的两个部位是眼睛和口腔。病变常导致瘢痕形成,可能导致失明。严重疾病或眼部受累的患者需要使用皮质类固醇和环磷酰胺进行积极治疗。获得性大疱性表皮松解症是由基底膜锚定纤维中的 VII 型胶原自身免疫引起的。病变可能在炎症基础上发生,也可能是非炎症性的,主要由创伤引起。治疗选择包括皮质类固醇、氨苯砜、环孢素、甲氨蝶呤和血浆置换/免疫吸附。副肿瘤性天疱疮是由多种桥粒抗原自身免疫引起的。该疾病与肿瘤有关,特别是白血病、淋巴瘤和胸腺瘤。患者表现为口炎和多形性皮肤疹。该疾病可能对潜在肿瘤的成功治疗有反应,也可能需要免疫抑制治疗。

相似文献

1
Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management.老年人自身免疫性大疱性皮肤病:病理生理学、诊断和治疗的最新进展。
Drugs Aging. 2010 Jan 1;27(1):1-19. doi: 10.2165/11318600-000000000-00000.
2
Autoimmune bullous dermatoses in the elderly: diagnosis and management.老年人自身免疫性大疱性皮肤病:诊断与管理
Drugs Aging. 2003;20(9):663-81. doi: 10.2165/00002512-200320090-00004.
3
Autoimmune bullous diseases: diagnosis and management.自身免疫性大疱性疾病:诊断与管理
Dermatol Nurs. 2006 Feb;18(1):20-5.
4
Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.自身免疫性大疱性皮肤病治疗共识:大疱性类天疱疮、黏膜类天疱疮和获得性大疱性表皮松解症——巴西皮肤病学会
An Bras Dermatol. 2019 Apr;94(2 Suppl 1):33-47. doi: 10.1590/abd1806-4841.2019940207. Epub 2019 Jun 30.
5
Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.获得性大疱性表皮松解症的发病机制,一种自身免疫性表皮下水疱病。
J Pathol. 2012 Sep;228(1):1-7. doi: 10.1002/path.4062. Epub 2012 Jul 26.
6
Retrospective analysis of autoimmune bullous diseases in Middle Franconia.回顾性分析中弗兰肯地区的自身免疫性大疱性皮肤病。
Front Immunol. 2023 Oct 10;14:1256617. doi: 10.3389/fimmu.2023.1256617. eCollection 2023.
7
[Autoimmune bullous skin disorders].[自身免疫性大疱性皮肤病]
Ther Umsch. 2010 Sep;67(9):465-82. doi: 10.1024/0040-5930/a000080.
8
Bullous autoimmune dermatoses.大疱性自身免疫性皮肤病。
J Dtsch Dermatol Ges. 2018 Nov;16(11):1339-1358. doi: 10.1111/ddg.13688.
9
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.自身免疫性表皮下大疱性皮肤病:临床特征、诊断与治疗。
Clin Rev Allergy Immunol. 2018 Feb;54(1):26-51. doi: 10.1007/s12016-017-8633-4.
10
Epidermolysis bullosa acquisita.获得性大疱性表皮松解症。
An Bras Dermatol. 2022 Jul-Aug;97(4):409-423. doi: 10.1016/j.abd.2021.09.010. Epub 2022 Jun 11.

引用本文的文献

1
Epidermolysis bullosa acquisita.获得性大疱性表皮松解症。
An Bras Dermatol. 2022 Jul-Aug;97(4):409-423. doi: 10.1016/j.abd.2021.09.010. Epub 2022 Jun 11.
2
Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.自身免疫性大疱性皮肤病治疗共识:大疱性类天疱疮、黏膜类天疱疮和获得性大疱性表皮松解症——巴西皮肤病学会
An Bras Dermatol. 2019 Apr;94(2 Suppl 1):33-47. doi: 10.1590/abd1806-4841.2019940207. Epub 2019 Jun 30.
3
Thymoma and autoimmunity.

本文引用的文献

1
Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.采用免疫抑制药物疗法治疗眼部黏膜类天疱疮。
Ophthalmology. 2008 Dec;115(12):2146-2152.e1. doi: 10.1016/j.ophtha.2008.08.002. Epub 2008 Oct 18.
2
Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States.大疱性类天疱疮的死亡率:223例患者的评估及与美国普通人群死亡率的比较
J Am Acad Dermatol. 2008 Oct;59(4):582-8. doi: 10.1016/j.jaad.2008.07.022. Epub 2008 Aug 15.
3
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.
胸腺瘤与自身免疫。
Cell Mol Immunol. 2011 May;8(3):199-202. doi: 10.1038/cmi.2010.74. Epub 2011 Feb 14.
大疱性类天疱疮和寻常型天疱疮——英国的发病率和死亡率:基于人群的队列研究。
BMJ. 2008 Jul 9;337(7662):a180. doi: 10.1136/bmj.a180.
4
Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita.新生儿Fc受体缺陷可保护实验性获得性大疱性表皮松解症免受组织损伤。
J Mol Med (Berl). 2008 Aug;86(8):951-9. doi: 10.1007/s00109-008-0366-7. Epub 2008 Jun 10.
5
[Mucous membrane pemphigoid with ocular involvement. Part II: therapy].[伴有眼部受累的黏膜类天疱疮。第二部分:治疗]
Ophthalmologe. 2008 Apr;105(4):405-19. doi: 10.1007/s00347-008-1700-8.
6
Rituximab in treatment-resistant autoimmune blistering skin disorders.利妥昔单抗治疗难治性自身免疫性水疱性皮肤病
Clin Rev Allergy Immunol. 2008 Feb;34(1):56-64. doi: 10.1007/s12016-007-8021-6.
7
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases.免疫吸附疗法在自身免疫性大疱性疾病治疗中的应用建议。
J Dtsch Dermatol Ges. 2007 Oct;5(10):881-7. doi: 10.1111/j.1610-0387.2007.06342.x.
8
Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.使用抗CD20抗体利妥昔单抗成功辅助治疗顽固性黏膜类天疱疮。
J Drugs Dermatol. 2007 Jul;6(7):731-2.
9
Rituximab in autoimmune bullous diseases: mixed responses and adverse effects.利妥昔单抗治疗自身免疫性大疱性疾病:疗效不一及不良反应
Br J Dermatol. 2007 Feb;156(2):352-6. doi: 10.1111/j.1365-2133.2006.07646.x.
10
Rituximab in refractory autoimmune bullous diseases.利妥昔单抗治疗难治性自身免疫性大疱性疾病
Clin Exp Dermatol. 2006 Jul;31(4):503-8. doi: 10.1111/j.1365-2230.2006.02151.x.